In 2008, Pfizer decided to pull out of Michigan, a move the state largely greeted with dismay and frustration. Here was a major pharmaceutical company abandoning a region already starving for well-paid, high tech jobs.
In the end, it just might have been the best thing to ever happen in Michigan.
From Pfizer’s exit arose two institutions key to the state’s high tech future: the Michigan Life Science & Innovation Center (MLSIC) in Plymouth and the University of Michigan’s North Campus Research Complex (NCRC) in Ann Arbor.
To read the full, original article click on this link: From Lab To Incubator To Accelerator, We Have The Makings Of An Innovation Factory In Michigan | Xconomy
Author:
Thomas Lee
